DNA Print Genomics 

$0.000001
4
-$0.00-95%Friday 18:29

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.00002
52W Low
0.000001
Volume
331,500
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Jan 1Expected
Q4 0
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap41.23B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with DNA Print Genomics.
Pacific Biosciences of California
PACB
Mkt Cap789.51M
Pacific Biosciences offers long-read sequencing technologies, competing in the genomic sequencing market.
Qiagen NV
QGEN
Mkt Cap9.24B
Qiagen is known for sample and assay technologies for molecular diagnostics, applying genomics in ways that overlap with DNA Print Genomics' market.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific provides analytical instruments and reagents, including for genomics, making it a competitor in the broader genomics and biotechnology field.
Bionano Genomics
BNGO
Mkt Cap17.43M
Bionano Genomics focuses on genomic analysis with its Saphyr system, offering an alternative approach to genetic testing and analysis.
Guardant Health
GH
Mkt Cap23.86B
Guardant Health offers liquid biopsy tests for cancer, which involves genomic analysis, placing it in competition with genomic diagnostic approaches.
Intellia Therapeutics
NTLA
Mkt Cap1.72B
Intellia Therapeutics is involved in CRISPR gene editing, a technology that competes in the broader genomics market by offering potential for genetic modifications and treatments.
Editas Medicine
EDIT
Mkt Cap402.38M
Editas Medicine also focuses on CRISPR gene editing, directly competing in the genomic medicine space with potential applications overlapping those of DNA Print Genomics.
CRISPR Therapeutics
CRSP
Mkt Cap5.36B
CRISPR Therapeutics is engaged in gene-based medicine, competing in the genomic editing and therapy market, which impacts the broader genomics industry.

About

DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an individual's fundamental continental European heritage. In forensic science, DNAWitness assists in determining genetic background from crime scene samples, while RETINOME is utilized by detectives to construct physical traits, such as eye color, from DNA evidence or human remains. Furthermore, the company provides the GenomeLab SNPstream Genotyping System, recognized for its high genotyping throughput, multiplexing capabilities, and efficient reagent usage. DNAPrint Genomics caters to diverse clients in fields like forensic investigation, genealogical exploration, consumer products, and pharmaceutical research. Originally incorporated in 1983 as Lexington Energy, Inc., the company operates from Sarasota, Florida, with an international presence through a subsidiary in Leverkusen, Germany.
Show More
CEO
Jatin Patel
Employees
24
Country
United States
ISIN
US23324Q2021

Listings

0 Comments

Share your thoughts

FAQs

What is DNA Print Genomics stock price today?▼
The current price of DNAG is $0.00 USD — it has decreased by -95% in the past 24 hours. Watch DNA Print Genomics stock price performance more closely on the chart.
What is DNA Print Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange DNA Print Genomics stocks are traded under the ticker DNAG.
Is DNA Print Genomics stock price growing?▼
DNAG stock has fallen by -95% compared to the previous week, the month change is a -95% fall, over the last year DNA Print Genomics has showed a -90% decrease.
How many employees does DNA Print Genomics have?▼
As of November 2, 2026, the company has 24 employees.
In which sector is DNA Print Genomics located?▼
DNA Print Genomics operates in the Health & Wellness sector.
When did DNA Print Genomics complete a stock split?▼
DNA Print Genomics has not had any recent stock splits.
Where is DNA Print Genomics headquartered?▼
DNA Print Genomics is headquartered in Sarasota, United States.